EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced the appointment of Al Lustig as its new president. Reporting directly to EVIO CEO William Waldrop, Lustig’s primary responsibility in this position will be to drive the company’s growth in both new and existing markets by developing and executing national and international sales and operational strategies. “As we embark upon our next stage of rapid growth, Al’s history of recognized success in corporate growth and sales leadership at Pfizer, one of the world’s largest bio-pharmaceutical companies, makes him the perfect fit to help lead EVIO into 2018 and beyond,” Waldrop stated in the news release. “We look forward to leveraging Al’s leadership and expertise from the pharmaceutical sector. Current EVIO President and Chief Operating Officer Lori Glauser has resigned from her position as President to make room for Al in the Senior Leadership team. Ms. Glauser will remain with the company as Chief Operating Officer, leading both our advisory services division and laboratory expansion.”
To view the full press release, visit http://cnw.fm/m2Kvl
About EVIO, Inc.
EVIO, Inc. is a life sciences company focused on analyzing cannabis as a means for improving quality of life. The Company provides analytical testing services, advisory services and performs product research in its accredited laboratory testing facilities. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. For more information, visit www.EvioLabs.com
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com